Tenaya Therapeutics, Inc. Research And Development Expense

Quick Answer

Tenaya Therapeutics, Inc. reported Research And Development Expense of $68.61 million for the year ending 2025.

  • Tenaya Therapeutics, Inc. showed a decrease of -20.9% in Research And Development Expense from 2024 to 2025.
  • This data is from Tenaya Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), Tenaya Therapeutics, Inc.'s Research And Development Expense has grown by 120.6%.
  • Historical annual values: Fiscal year 2025: $68.61 million | Fiscal year 2024: $86.74 million | Fiscal year 2023: $98.04 million | Fiscal year 2022: $94.54 million | Fiscal year 2021: $54.39 million | Fiscal year 2020: $31.10 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: